European leader in providing services for the evaluation of gene therapy products, GenoSafe team specializes in the evaluation of cellular and gene therapy products (gene therapy products, vaccines, etc …)
Wide spectrum expertise
GenoSafe offers its expertise in various stages, from proof of concept to the placing on the market of a product and works for very different customers. Academic organizations (Institut Pasteur , INSERM, AP- HP … ) to biotech wchich have an innovating project therapy and for Genethon for several of its projects. ( Preclinical studies , clinical , quality control vector batches , Regulatory Affairs) .
“Contributing to the development of therapies of tomorrow”
Serge Braun, President and Scientific Director GenoSafe AFM – Telethon , explains: ” The expertise Genethon , supplemented by GenoSafe team , can develop the expertise developed in the scope of the AFM- Telethon and its laboratories . GenoSafe clients , mostly from the biotechnology sector , multiply and GenoSafe contributes to the emergence of therapies of tomorrow. ”
GenoSafe is a partner of national collaborative projects (ADNA , PGT ) and international ( Target- AMD Net4CGD , MeuSix ) bringing together the major players in academia and industry , in the field of advanced therapy medicinal products .
For this 10th anniversary GenoSafe inaugurates its new website to discover here !
